Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2025
Suzetrigine: First Approval.
Susan J Keam
PubMed ↗
Publisher ↗
No numbers read from the abstract.
17 papers cite it
2025
2026
this paper
trial
cites it
The trial
NCT07600697
phase 4
120 enrolled
2026
Suzetrigine: First Approval. | OpenQuestion